University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center — Birmingham, Alabama

University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center is a clinical research site located in Birmingham, Alabama, United States 35249.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Brain Metastases, Essential Tremor, Parkinson Disease.

Sponsors: University of Alabama at Birmingham.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center?

University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center conducted?

University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center has 2 clinical trials on record, with 2 currently active. Their work covers Brain Metastases, Essential Tremor, Parkinson Disease.

Is University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center accredited by Crixeo Health?

University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.